Search Results
Viewing: 771-780 of 3552 | All
Article
September 2011
Dr. Jill Rafael-Fortney discusses the effects of Lisinopril and Spironolactone on DMD mice.
Article
October 2010
Dr. Annemieke Aartsma-Rus discusses progress in antisense oligonucleotide therapies.
Article
Timothy Cripe Lab
Under the direction of Timothy Cripe, MD, PhD, the Cripe Lab focuses on developing and testing new, targeted therapies for pediatric solid tumors and translating those findings into clinical studies.
Article
Timothy Cripe Lab Staff
Timothy P. Cripe, MD, PhD Principal Investigator Timothy Cripe, MD, PhD, is the chief of the Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant and the Gordon Teter endowed chair in pediatric cancer at Nationwide Children’s Hospital.
News
Saliva, Genomic Analysis Used to Identify Promising Biomarkers for Persistent Post-Concussive Symptoms in Children
In a study published in Frontiers in Public Health, researchers with the Center for Injury Research and Policy, Division of Sports Medicine, and the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital have demonstrated a method by which increased risk of persistent post-concussive symptoms (PPCS) in children with concussion can be identified. This could allow families and their care teams to better assess recovery time of children with concussion.
Article
Brain Development and Social Cognition Lab Staff
Learn more about principal investigator Eric Nelson, PhD, and his dynamic team in the Brain Development and Social Cognition Lab.
Article
Zepeda-Orozco Lab Staff
Diana Zepeda-Orozco, MD Principal Investigator Diana.Zepeda-Orozco@NationwideChildrens.org Diana Zepeda-Orozco, MD, is a principal investigator in the Kidney and Urinary Tract Research Center within the Abigail Wexner Research Institute at Nationwide Children's Hospital, an attending physician and